Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: A pooled analysis of affirm and AF-CHF trials

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 12, 2014, Pages 1306-1313

  Cadrin Tourigny, Julia ^a   Wyse, D G ^b   Roy, Denis ^a   Blondeau, Lucie ^a   Levesque, Sylvie ^a   Talajic, Mario ^a   Andrade, Jason G ^a   Dubuc, Marc ^a   Thibault, Bernard ^a   Guerra, Peter G ^a   Macle, Laurent ^a   Rivard, Lena ^a   Khairy, Paul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

AF CHF trial; AFFIRM trial; amiodarone; antiarrhythmic drug; atrial fibrillation; heart failure

Indexed keywords

AMIODARONE; ANTILIPEMIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VERAPAMIL; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; ATRIAL FIBRILLATION; DEATH, SUDDEN, CARDIAC; MORTALITY; PREVALENCE; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DEATH, SUDDEN, CARDIAC; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84926420366     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12535     Document Type: Article

References (33)

1. Cha YM, Redfield MM, Shen WK, Gersh BJ,: Atrial fibrillation and ventricular dysfunction: A vicious electromechanical cycle. Circulation 2004; 109: 2839-2843.
2. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD,: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
3. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL,: Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-2677.
4. Hohnloser SH, Kuck KH, Lilienthal J,: Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial. Lancet 2000; 356: 1789-1794.
5. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ,: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
6. Frasure-Smith N, Lesperance F, Talajic M, Khairy P, Dorian P, O'Meara E, Roy D,: Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: Insights from the Atrial Fibrillation and Congestive Heart Failure Trial. Circ Heart Fail 2012; 5: 322-330.
7. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B,: Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000; 342: 913-920.
8. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Raisch DW, Ezekowitz MD,: Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005; 352: 1861-1872.
9. Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J,: Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2012; 5: CD005049.
10. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997; 350: 1417-1424.
11. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS,: ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2011; 57: e101-198.
12. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U,: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003; 41: 1690-1696.
13. Kochiadakis GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE,: Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: A comparative, placebo controlled study. Heart 2000; 84: 251-257.
14. Atrial fibrillation follow-up investigation of rhythm management: The AFFIRM study design. Am J Cardiol 1997; 79: 1198-1202.
15. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002; 144: 597-607.
16. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG,: Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004; 109: 1509-1513.
17. Galperin J, Elizari MV, Chiale PA, Molina RT, Ledesma R, Scapin AO, Vazquez Blanco M,: Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: A prospective, multicenter, randomized, controlled, double blind trial. J Cardiovasc Pharmacol Ther 2001; 6: 341-350.
18. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN,: Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation 1998; 98: 2574-2579.
19. Vaziri SM, Larson MG, Benjamin EJ, Levy D,: Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89: 724-730.
20. Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN,: Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995; 76: 47-50.
21. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA,: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
22. Movahed MR, Hashemzadeh M, Jamal MM,: Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315-318.
23. Watanabe M, Yokoshiki H, Mitsuyama H, Mizukami K, Ono T, Tsutsui H,: Conduction and refractory disorders in the diabetic atrium. Am J Physiol Heart Circ Physiol 2012; 303: H86-95.
24. Piccini JP, Berger JS, O'Connor CM,: Amiodarone for the prevention of sudden cardiac death: A meta-analysis of randomized controlled trials. Eur Heart J 2009; 30: 1245-1253.
25. Breitenstein A, Stampfli SF, Camici GG, Akhmedov A, Ha HR, Follath F, Bogdanova A, Luscher TF, Tanner FC,: Amiodarone inhibits arterial thrombus formation and tissue factor translation. Arterioscler Thromb Vasc Biol 2008; 28: 2231-2238.
26. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R,: Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-498.
27. Naccarelli GV, Johnston SS, Dalal M, Lin J, Patel PP,: Rates and implications for hospitalization of patients ≥ 65 years of age with atrial fibrillation/flutter. Am J Cardiol 2012; 109: 543-549.
28. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ, Investigators A,: Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360: 668-678.
29. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
30. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D,: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
31. Khan MN, Jais P, Cummings J, Di Biase L, Sanders P, Martin DO, Kautzner J, Hao S, Themistoclakis S, Fanelli R, Potenza D, Massaro R, Wazni O, Schweikert R, Saliba W, Wang P, Al-Ahmad A, Beheiry S, Santarelli P, Starling RC, Dello Russo A, Pelargonio G, Brachmann J, Schibgilla V, Bonso A, Casella M, Raviele A, Haissaguerre M, Natale A, Investigators P-C,: Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359: 1778-1785.
32. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M,: Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383.
33. Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, Rossillo A, Verma A, Cummings J, Erciyes D, Saad E, Bhargava M, Bash D, Schweikert R, Burkhardt D, Williams-Andrews M, Perez-Lugones A, Abdul-Karim A, Saliba W, Natale A,: Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 2004; 43: 1004-1009.